The inspection closed with zero observations and a classification of No Action Indicated
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
The product is being launched in August 2023
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
The company has reported total income of Rs. 1248.51 crores during the period ended June 30, 2023
The company has secured 506 marketing approvals for its oncology products across 76 countries.
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Subscribe To Our Newsletter & Stay Updated